Open Access 01-12-2017 | Research
Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
Published in: Journal of Hematology & Oncology | Issue 1/2017
Login to get accessOpen Access 01-12-2017 | Research
Published in: Journal of Hematology & Oncology | Issue 1/2017
Login to get access